Delray Medical Center WATCHMAN FLX Device for Atrial Fibrillation Now Offered to Patients

Delray Medical Center now offers the WATCHMAN FLX™ for patients who have a high risk of stroke with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage-the area of the heart where stroke-causing blood clots commonly form in NAVF.

Delray Medical Center Dr. Martin Kloosterman, electrophysiologist on staff said, “People with atrial fibrillation are at an increased risk of stroke if they are not on blood thinners, which can also increase the risk of bleeding. This can often result in higher mortality and disability rates because of an injury to the brain or other affected areas.” He added, “We are pleased to have available a new generation of the Watchman FLX device, which expands the number of patients who can benefit from this life-saving technology.”

This technology features a new, fully rounded design offering physicians the ability to safely enter, and maneuver within the left atrial appendage.  It is the first LAAC device that can be fully recaptured, repositioned and redeployed for precise placement, and the new frame design allows for optimal device engagement with the tissue for long-term stability and a faster, more complete seal.

“This advanced technology gives us a new option to treat patients who are at high risk for stroke, that could also enable them to have a better long-term quality of life,” said Maggie Gill, chief executive officer for the Palm Beach Health Network and Delray Medical Center. “We remain committed to providing patients in Palm Beach County with comprehensive cardiovascular treatment options close to home, and in a safe environment.”

Atrial Fibrillation is a common heart disorder which occurs when electrical signals in the heart become irregular, causing the heart’s upper chamber to beat out of rhythm.  Atrial fibrillation requires immediate medical attention because it could lead to a life-threatening stroke, which is otherwise preventable.

When it comes to you, your family, and your health, Delray Medical Center and its cardiovascular team knows what it take to give you the care you need quickly and compassionately.  During a health emergency, you need health care you can trust.  At Delray Medical Center, we believe that is exactly what you will find.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.